SuperworthKORU Medical Systems profit margin KRMD
Gross, operating and net profit as a share of revenue over the last twelve months, from 2011.
- Net margin, 12 months
- −4.0%
- Operating margin, 12 months
- −3.7%
- Net margin on a year earlier
- +8.2 pts
- Peer median
- 6.9%
Over the twelve months to Jun 30, 2026, KORU Medical Systems kept −4.0% of its revenue as net profit, with an operating margin of −3.7% and a gross margin of 62.4%.
Five years earlier its net margin was −14.2%.
The median for 10 medical instruments and supplies stocks of a similar size is 6.9%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | −6.4% | −7.2% | 62.3% |
| FY2024 | −18.0% | −19.2% | 63.4% |
| FY2023 | −48.2% | −36.0% | 58.6% |
| FY2022 | −31.0% | −38.6% | 55.1% |
| FY2021 | −19.4% | −29.9% | 58.6% |
| FY2020 | −5.0% | −5.2% | 61.8% |
| FY2019 | 2.4% | 2.5% | 64.1% |
| FY2018 | 5.2% | 6.7% | 62.3% |
| FY2017 | n/a | n/a | n/a |
| FY2016 | 6.4% | 9.6% | 62.1% |
| FY2015 | 6.7% | 10.2% | 59.5% |
| FY2014 | 8.1% | 11.6% | 61.0% |
| FY2013 | 9.3% | 13.7% | 63.7% |
| FY2012 | 12.8% | 20.2% | 64.8% |
| FY2011 | 14.3% | 24.3% | 66.3% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | −4.0% | +8.2 pts | −3.7% | |
| Q1 FY26 | −5.3% | +9.8 pts | −6.0% | |
| Q4 FY25 | −6.4% | +11.6 pts | −7.2% | |
| Q3 FY25 | −9.5% | +27.9 pts | −10.3% | |
| Q2 FY25 | −12.3% | +25.9 pts | −13.2% | |
| Q1 FY25 | −15.1% | +30.1 pts | −16.3% | |
| Q4 FY24 | −18.0% | +30.2 pts | −19.2% | |
| Q3 FY24 | −37.4% | −8.6 pts | −22.0% | |
| Q2 FY24 | −38.2% | −10.6 pts | −23.2% | |
| Q1 FY24 | −45.2% | −15.9 pts | −31.3% | |
| Q4 FY23 | −48.2% | −17.1 pts | −36.0% | |
| Q3 FY23 | −28.8% | −0.1 pts | −36.9% |
Against its peers
Companies in Medical - Instruments & Supplies nearest KORU Medical Systems' size, closest first, today.
| Company | Profit margin |
|---|---|
| KRMDKORU Medical Systems | −4.0% |
| PDEXPro DEX | 17.6% |
| KEQUKewaunee Scientific | 3.0% |
| UTMDUtah Medical Products | 29.0% |
| INFUInfuSystem | 6.0% |
| APTAlpha Pro Tech | 6.8% |
| EMBCEmbecta | 8.6% |
| TCMDTactile Systems Technology | 7.1% |
| NEPHNephros | 8.4% |
| MDXGMimedx | 1.8% |
| MOVMovado | 6.0% |
| Peer median | 6.9% |
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on KORU Medical Systems
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.